• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在慢性阻塞性肺疾病急性加重期的治疗过程中,气道炎症和抗蛋白酶防御功能迅速改善。

Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD.

作者信息

Pant Sushil, Walters Eugene H, Griffiths Anne, Wood-Baker Richard, Johns David P, Reid David W

机构信息

Cardio-Respiratory Research Group, Menzies Research Institute, University of Tasmania, Australia.

出版信息

Respirology. 2009 May;14(4):495-503. doi: 10.1111/j.1440-1843.2009.01517.x.

DOI:10.1111/j.1440-1843.2009.01517.x
PMID:19645868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7190194/
Abstract

BACKGROUND AND OBJECTIVE

There are few data on the short-term natural history of airway inflammation during severe episodes of acute exacerbation of COPD (AECOPD). An observational study was performed to determine how rapidly conventional treatment improves airway inflammation in patients admitted to hospital with AECOPD.

METHODS

Twenty-four consecutive patients with AECOPD were recruited and changes in sputum inflammatory indices were assessed after 2 and 4 days of treatment. The primary end-points included presence of bacteria and viruses, changes in sputum total cell counts (TCC) and polymorphonuclear leukocyte (PMN) differential counts, and levels of secretory leukocyte protease inhibitor (SLPI), IL-8 and TNF-alpha.

RESULTS

All patients received oral corticosteroids and 17 (71%) were also treated with oral antibiotics. A bacterial or viral pathogen was isolated from 12 patients (50%), and Aspergillus fumigatus was isolated from one. A positive bacterial culture was associated with increased sputum TCC and PMN count (P < 0.05), as well as higher levels of IL-8 and TNF-alpha (P < 0.05), and a trend towards lower sputum SLPI levels (P = 0.06). Sputum PMN numbers fell by 70% within the first 48 h of admission (P < 0.05), accompanied by an increase in sputum SLPI (P < 0.001) and reductions in the levels of TNF-alpha (P < 0.005) and IL-8 (P = 0.06), with no further significant change at 4 days.

CONCLUSIONS

Conventional treatment for severe AECOPD is associated with rapid reduction of neutrophilic inflammation and improvement in anti-protease defences.

摘要

背景与目的

关于慢性阻塞性肺疾病急性加重(AECOPD)严重发作期间气道炎症的短期自然史的数据较少。进行了一项观察性研究,以确定常规治疗能多快改善因AECOPD入院患者的气道炎症。

方法

连续招募了24例AECOPD患者,并在治疗2天和4天后评估痰液炎症指标的变化。主要终点包括细菌和病毒的存在情况、痰液总细胞计数(TCC)和多形核白细胞(PMN)分类计数的变化,以及分泌型白细胞蛋白酶抑制剂(SLPI)、白细胞介素-8(IL-8)和肿瘤坏死因子-α(TNF-α)的水平。

结果

所有患者均接受口服皮质类固醇治疗,17例(71%)还接受了口服抗生素治疗。从12例患者(50%)中分离出细菌或病毒病原体,从1例患者中分离出烟曲霉。阳性细菌培养与痰液TCC和PMN计数增加(P < 0.05)、IL-8和TNF-α水平升高(P < 0.05)以及痰液SLPI水平呈降低趋势(P = 0.06)相关。入院后最初48小时内痰液PMN数量下降了70%(P < 0.05),同时痰液SLPI增加(P < 0.001),TNF-α(P < 0.005)和IL-8水平降低(P = 0.06),4天时无进一步显著变化。

结论

重度AECOPD的常规治疗与中性粒细胞炎症的快速减轻和抗蛋白酶防御功能的改善有关。

相似文献

1
Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD.在慢性阻塞性肺疾病急性加重期的治疗过程中,气道炎症和抗蛋白酶防御功能迅速改善。
Respirology. 2009 May;14(4):495-503. doi: 10.1111/j.1440-1843.2009.01517.x.
2
Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.卡他莫拉菌的获得、慢性阻塞性肺疾病的气道炎症和蛋白酶-抗蛋白酶平衡。
BMC Infect Dis. 2009 Nov 15;9:178. doi: 10.1186/1471-2334-9-178.
3
Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期的粒细胞炎症标志物与气道感染
Am J Respir Crit Care Med. 2001 Feb;163(2):349-55. doi: 10.1164/ajrccm.163.2.2003122.
4
Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.抗菌肽水平与慢性阻塞性肺疾病的气道炎症、细菌定植和恶化有关。
Eur Respir J. 2017 Mar 15;49(3). doi: 10.1183/13993003.01328-2016. Print 2017 Mar.
5
Systemic Inflammatory Marker CRP Was Better Predictor of Readmission for AECOPD Than Sputum Inflammatory Markers.全身炎症标志物CRP比痰液炎症标志物更能预测慢性阻塞性肺疾病急性加重(AECOPD)的再入院情况。
Arch Bronconeumol. 2016 Mar;52(3):138-44. doi: 10.1016/j.arbres.2015.01.011. Epub 2015 May 20.
6
Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).α1-抗胰蛋白酶缺乏症(PiZ型)患者在慢性阻塞性肺疾病急性加重期存在支气管过度炎症的证据。
Am J Respir Crit Care Med. 1999 Dec;160(6):1968-75. doi: 10.1164/ajrccm.160.6.9904097.
7
Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.门诊 COPD 患者从稳定期到随后加重期炎症变化。
Int J Chron Obstruct Pulmon Dis. 2009;4:101-9. doi: 10.2147/copd.s4854. Epub 2009 Apr 15.
8
Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease.基于痰液炎症细胞分类的慢性阻塞性肺疾病急性加重患者。
PLoS One. 2013 May 31;8(5):e57678. doi: 10.1371/journal.pone.0057678. Print 2013.
9
Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.左氧氟沙星对稳定期 COPD 中性粒细胞气道炎症的影响:一项随机、双盲、安慰剂对照试验。
Int J Chron Obstruct Pulmon Dis. 2014 Feb 7;9:179-86. doi: 10.2147/COPD.S55419. eCollection 2014.
10
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.鼻病毒感染导致慢性阻塞性肺疾病中抗菌肽的降解和继发细菌感染。
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1117-24. doi: 10.1164/rccm.201205-0806OC. Epub 2012 Sep 28.

引用本文的文献

1
Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations.慢性阻塞性肺疾病加重的定义、病因、发病机制及后果。
Clin Chest Med. 2020 Sep;41(3):421-438. doi: 10.1016/j.ccm.2020.06.007.
2
Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19.金属蛋白酶抑制在新型冠状病毒肺炎所致严重肺损伤治疗中的应用
Med Drug Discov. 2020 Sep;7:100052. doi: 10.1016/j.medidd.2020.100052. Epub 2020 Jun 5.
3
Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.皮质类固醇抑制抗病毒免疫会增加 COPD 恶化时的细菌负荷和黏液产生。
Nat Commun. 2018 Jun 8;9(1):2229. doi: 10.1038/s41467-018-04574-1.
4
The Expression of IL-6, TNF-, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.白细胞介素-6、肿瘤坏死因子-α 和单核细胞趋化蛋白-1 在慢性阻塞性肺疾病急性加重期呼吸道病毒感染中的表达。
J Immunol Res. 2017;2017:8539294. doi: 10.1155/2017/8539294. Epub 2017 Mar 2.
5
The Anti-inflammatory Effect of Alpha-1 Antitrypsin in Rhinovirus-infected Human Airway Epithelial Cells.α1抗胰蛋白酶在鼻病毒感染的人气道上皮细胞中的抗炎作用
J Clin Cell Immunol. 2016 Dec;7(6). doi: 10.4172/2155-9899.1000475. Epub 2016 Dec 5.
6
Respiratory Viral Infections in Chronic Lung Diseases.慢性肺部疾病中的呼吸道病毒感染
Clin Chest Med. 2017 Mar;38(1):87-96. doi: 10.1016/j.ccm.2016.11.014. Epub 2016 Dec 24.
7
Bacteria in COPD; their potential role and treatment.慢性阻塞性肺疾病中的细菌;它们的潜在作用及治疗
Transl Respir Med. 2013 Dec;1(1):13. doi: 10.1186/2213-0802-1-13. Epub 2013 Aug 30.
8
The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.病毒感染在慢性阻塞性肺疾病和哮喘急性加重中的作用。
Ther Adv Respir Dis. 2016 Apr;10(2):158-74. doi: 10.1177/1753465815618113. Epub 2015 Nov 26.
9
Time course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病频繁急性加重患者炎症消退的时间进程。
Med Sci Monit. 2014 Feb 25;20:311-20. doi: 10.12659/MSM.889828.
10
Experimental rhinovirus infection in COPD: implications for antiviral therapies.慢性阻塞性肺疾病患者的鼻病毒感染:抗病毒治疗的意义。
Antiviral Res. 2014 Feb;102:95-105. doi: 10.1016/j.antiviral.2013.12.006. Epub 2013 Dec 24.

本文引用的文献

1
The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses.分泌型白细胞蛋白酶抑制剂在炎症反应消退中的作用。
Biochem Soc Trans. 2007 Apr;35(Pt 2):273-6. doi: 10.1042/BST0350273.
2
Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews.全身用皮质类固醇治疗慢性阻塞性肺疾病:Cochrane系统评价概述
Respir Med. 2007 Mar;101(3):371-7. doi: 10.1016/j.rmed.2006.07.013. Epub 2006 Sep 7.
3
Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期血浆生物标志物的应用。
Am J Respir Crit Care Med. 2006 Oct 15;174(8):867-74. doi: 10.1164/rccm.200604-506OC. Epub 2006 Jun 23.
4
Role of viral infections in asthma and chronic obstructive pulmonary disease.病毒感染在哮喘和慢性阻塞性肺疾病中的作用。
Am J Respir Cell Mol Biol. 2006 Nov;35(5):513-8. doi: 10.1165/rcmb.2006-0199TR. Epub 2006 Jun 15.
5
[Pathogenesis of chronic obstructive pulmonary disease. Cellular mechanisms (part I)].[慢性阻塞性肺疾病的发病机制。细胞机制(第一部分)]
Wiad Lek. 2006;59(1-2):92-6.
6
Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.下呼吸道细菌与鼻病毒感染之间的相互作用对慢性阻塞性肺疾病急性加重的影响。
Chest. 2006 Feb;129(2):317-324. doi: 10.1378/chest.129.2.317.
7
MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.慢性阻塞性肺疾病(COPD)患者急性加重期痰液中的基质金属蛋白酶-9(MMP-9)、金属蛋白酶组织抑制因子-1(TIMP-1)和炎性细胞
Respir Res. 2005 Dec 22;6(1):151. doi: 10.1186/1465-9921-6-151.
8
Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?慢性阻塞性肺疾病急性加重期的细菌:是现象还是附带现象?
Proc Am Thorac Soc. 2004;1(2):109-14. doi: 10.1513/pats.2306029.
9
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes.糖皮质激素作用于粒细胞的抗炎机制。
Curr Drug Targets Inflamm Allergy. 2005 Aug;4(4):455-63. doi: 10.2174/1568010054526331.
10
Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD.慢性阻塞性肺疾病严重加重期的亚硝化应激、血红素加氧酶-1表达与气道炎症
Chest. 2005 Jun;127(6):1911-8. doi: 10.1378/chest.127.6.1911.